We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$998M
AUM Growth
+$225M
Cap. Flow
+$186M
Cap. Flow %
18.64%
Top 10 Hldgs %
14.67%
Holding
843
New
316
Increased
131
Reduced
122
Closed
270

Sector Composition

Rank Sector Weight
1 Healthcare 19.66%
2 Consumer Discretionary 12.61%
3 Technology 12.15%
4 Financials 10.74%
5 Communication Services 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GKOS icon
51
Glaukos
GKOS
$8.89B
$4.57M 0.46%
88,981
+52,933
+147% +$2.31M
AAP icon
52
Advance Auto Parts
AAP
$3.54B
$4.54M 0.46%
30,613
-3,748
-11% -$602K
UNIT
53
Uniti Group
UNIT
$2.53B
$4.44M 0.45%
171,927
-86,740
-34% -$2.31M
HSKA
54
DELISTED
Heska Corp
HSKA
$4.41M 0.44%
41,983
+21,710
+107% +$1.86M
TFCFA
55
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$4.37M 0.44%
135,035
-137,840
-51% -$4.21M
KPTI icon
56
Karyopharm Therapeutics
KPTI
$161M
$4.37M 0.44%
+22,667
New +$3.64M
IART icon
57
Integra LifeSciences
IART
$1.54B
$4.3M 0.43%
102,087
+31,465
+45% +$1.34M
THO icon
58
Thor Industries
THO
$4.13B
$4.3M 0.43%
+44,731
New +$4.64M
PK icon
59
Park Hotels & Resorts
PK
$3.06B
$4.27M 0.43%
+166,349
New +$4.42M
LOXO
60
DELISTED
Loxo Oncology, Inc
LOXO
$4.21M 0.42%
100,047
+53,147
+113% +$2.19M
PARA
61
DELISTED
Paramount Global Class B
PARA
$4.19M 0.42%
60,366
-26,682
-31% -$1.75M
GNMK
62
DELISTED
GenMark Diagnostics, Inc
GNMK
$4.17M 0.42%
+325,000
New +$3.91M
KMX icon
63
CarMax
KMX
$8.36B
$4.14M 0.42%
+70,000
New +$4.55M
CHMI
64
Cherry Hill Mortgage Investment Corp
CHMI
$81.9M
$4.13M 0.41%
+241,828
New +$4.39M
TIVO
65
DELISTED
Tivo Inc
TIVO
$4.07M 0.41%
217,028
+61,036
+39% +$1.17M
USB icon
66
US Bancorp
USB
$100B
$4.05M 0.41%
78,567
+71,978
+1,092% +$3.84M
IMGN
67
DELISTED
Immunogen Inc
IMGN
$3.97M 0.4%
1,025,176
+250,176
+32% +$730K
MRO
68
DELISTED
Marathon Oil Corporation
MRO
$3.88M 0.39%
245,507
+169,317
+222% +$2.78M
EXEL icon
69
Exelixis
EXEL
$14.2B
$3.87M 0.39%
178,634
+34,800
+24% +$708K
TFC icon
70
Truist Financial
TFC
$64.7B
$3.83M 0.38%
+85,754
New +$4.01M
PEN icon
71
Penumbra
PEN
$12.6B
$3.83M 0.38%
45,941
+29,135
+173% +$2.21M
SBAC icon
72
SBA Communications
SBAC
$18.6B
$3.82M 0.38%
31,704
-44,540
-58% -$4.92M
HLNE icon
73
Hamilton Lane
HLNE
$3.91B
$3.8M 0.38%
+203,725
New +$3.82M
INTU icon
74
Intuit
INTU
$85.6B
$3.79M 0.38%
32,699
+19,106
+141% +$2.29M
CVLT icon
75
Commault Systems
CVLT
$4.97B
$3.79M 0.38%
74,600
+70,122
+1,566% +$3.58M

Similar funds

Schonfeld Strategic Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Schonfeld Strategic Advisors held 843 positions worth $998M, up 29% from $772M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Schonfeld Strategic Advisors deployed $186M of net new capital in Q1 2017, opening 316 new positions and adding to 131 existing holdings. Its largest new stake was AMC Entertainment Holdings: 113,380 shares worth $35.7M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $8.19M trimmed.

  • Schonfeld Strategic Advisors's largest Q1 2017 buy was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
  • Schonfeld Strategic Advisors added most to Athene Holding Ltd. Class A Common Shares in Q1 2017, an estimated $16.5M increase.
  • Schonfeld Strategic Advisors's biggest Q1 2017 reduction was AbbVie, cutting an estimated $8.19M.
  • Schonfeld Strategic Advisors fully exited Independence Realty Trust in Q1 2017, selling an estimated $8.78M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 15% of its $998M portfolio in Q1 2017.
  • Schonfeld Strategic Advisors opened 316 new positions and closed 270 in Q1 2017.
  • Schonfeld Strategic Advisors's portfolio value rose 29% quarter-over-quarter to $998M.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.